85 related articles for article (PubMed ID: 27403776)
1. Outcomes Following Bone Marrow Transplantation in Children With Accelerated Phase or Blast Crisis Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.
Shulman DS; Lee MA; Lehmann LE; Margossian SP
J Pediatr Hematol Oncol; 2016 Nov; 38(8):610-614. PubMed ID: 27403776
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Pretransplant Use of Tyrosine Kinase Inhibitors on Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia - A Single-institution Retrospective Study.
Fujita S; Kasahara H; Kato J; Koda Y; Shiroshita K; Yamaguchi K; Okayama M; Abe R; Kikuchi T; Shimizu T; Mori T; Kataoka K; Okamoto S
Intern Med; 2024 Jun; 63(11):1549-1562. PubMed ID: 37899244
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract][Full Text] [Related]
4. A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity.
Efstathopoulou M; Zoi K; Siakantaris MP; Koumbi D; Zannou A; Triantafyllou EF; Tsourouflis G; Lakiotaki E; Vassilakopoulos TP; Angelopoulou MK
Acta Haematol; 2023; 146(6):530-537. PubMed ID: 37557081
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia.
Senapati J; Jabbour E; Kantarjian H; Short NJ
Leukemia; 2023 Jan; 37(1):5-17. PubMed ID: 36309558
[TBL] [Abstract][Full Text] [Related]
6. Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era - forgotten but not gone.
Tang K; Lipton JH
Leuk Lymphoma; 2024 Jun; 65(6):705-714. PubMed ID: 38335007
[TBL] [Abstract][Full Text] [Related]
7. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Brioli A; Lomaia E; Fabisch C; Sacha T; Klamova H; Morozova E; Golos A; Ernst P; Olsson-Stromberg U; Zackova D; Nicolini FE; Bao H; Castagnetti F; Patkowska E; Mayer J; Hirschbühl K; Podgornik H; Paczkowska E; Parry A; Ernst T; Voskanyan A; Szczepanek E; Saussele S; Franke GN; Kiani A; Faber E; Krause S; Casado LF; Lewandowski K; Eder M; Anhut P; Gil J; Südhoff T; Hebart H; Heibl S; Pfirrmann M; Hochhaus A; Lauseker M
Leukemia; 2024 May; 38(5):1072-1080. PubMed ID: 38548962
[TBL] [Abstract][Full Text] [Related]
8. Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.
Jabbour EJ; Hughes TP; Cortés JE; Kantarjian HM; Hochhaus A
Leuk Lymphoma; 2014 Jul; 55(7):1451-62. PubMed ID: 24050507
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model.
Imeri J; Marcoux P; Huyghe M; Desterke C; Fantacini DMC; Griscelli F; Covas DT; de Souza LEB; Griscelli AB; Turhan AG
Front Immunol; 2023; 14():1309010. PubMed ID: 38259442
[TBL] [Abstract][Full Text] [Related]
10. The treatment of pediatric chronic myelogenous leukemia in the imatinib era.
Lee JW; Chung NG
Korean J Pediatr; 2011 Mar; 54(3):111-6. PubMed ID: 21738540
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in the proportion of "cure" in children, adolescents, and young adults diagnosed with chronic myeloid leukemia in England: A population-based study.
Drozdov D; Bonaventure A; Nakata K; Suttorp M; Belot A
Pediatr Blood Cancer; 2018 Dec; 65(12):e27422. PubMed ID: 30168243
[TBL] [Abstract][Full Text] [Related]
12. The Contemporary Role of Hematopoietic Stem Cell Transplantation in the Management of Chronic Myeloid Leukemia: Is It the Same in All Settings?
Elmakaty I; Saglio G; Al-Khabori M; Elsayed A; Elsayed B; Elmarasi M; Elsabagh AA; Alshurafa A; Ali E; Yassin M
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398145
[TBL] [Abstract][Full Text] [Related]
13. De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Hornak T; Mayer J; Cicatkova P; Semerad L; Kvetkova A; Klamova H; Faber E; Belohlavkova P; Karas M; Stejskal L; Cmunt E; Cerna O; Srbova D; Zizkova H; Vrablova L; Skoumalova I; Voglova J; Jurkova T; Chrapava M; Jurcek T; Jeziskova I; Jarosova M; Machova Polakova K; Papajik T; Zak P; Jindra P; Zackova D
Am J Hematol; 2024 Apr; 99(4):763-766. PubMed ID: 38317312
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor.
Parsi M; Budak-Alpdogan T
Cureus; 2020 Mar; 12(3):e7217. PubMed ID: 32274275
[TBL] [Abstract][Full Text] [Related]
15. Management of Chronic Myeloid Leukemia in Advanced Phase.
Bonifacio M; Stagno F; Scaffidi L; Krampera M; Di Raimondo F
Front Oncol; 2019; 9():1132. PubMed ID: 31709190
[TBL] [Abstract][Full Text] [Related]
16. Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.
Carter BZ; Mak PY; Mu H; Zhou H; Mak DH; Schober W; Leverson JD; Zhang B; Bhatia R; Huang X; Cortes J; Kantarjian H; Konopleva M; Andreeff M
Sci Transl Med; 2016 Sep; 8(355):355ra117. PubMed ID: 27605552
[TBL] [Abstract][Full Text] [Related]
17. Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.
Radich JP; Deininger M; Abboud CN; Altman JK; Berman E; Bhatia R; Bhatnagar B; Curtin P; DeAngelo DJ; Gotlib J; Hobbs G; Jagasia M; Kantarjian HM; Maness L; Metheny L; Moore JO; Pallera A; Pancari P; Patnaik M; Purev E; Rose MG; Shah NP; Smith BD; Snyder DS; Sweet KL; Talpaz M; Thompson J; Yang DT; Gregory KM; Sundar H
J Natl Compr Canc Netw; 2018 Sep; 16(9):1108-1135. PubMed ID: 30181422
[TBL] [Abstract][Full Text] [Related]
18. Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Sembill S; Ampatzidou M; Chaudhury S; Dworzak M; Kalwak K; Karow A; Kiani A; Krumbholz M; Luesink M; Naumann-Bartsch N; De Moerloose B; Osborn M; Schultz KR; Sedlacek P; Giona F; Zwaan CM; Shimada H; Versluijs B; Millot F; Hijiya N; Suttorp M; Metzler M
Leukemia; 2023 Mar; 37(3):505-517. PubMed ID: 36707619
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children.
Phillips LN; Hijiya N
Paediatr Drugs; 2021 May; 23(3):241-251. PubMed ID: 33899163
[TBL] [Abstract][Full Text] [Related]
20. Paediatric chronic myeloid leukaemia: Is it really a different disease?
Pushpam D; Bakhshi S
Indian J Med Res; 2019 May; 149(5):600-609. PubMed ID: 31417027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
